VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.
about
A Synthetic Heterobivalent Ligand Composed of Glucagon-Like Peptide 1 and Yohimbine Specifically Targets β Cells Within the PancreasCross-sectional and Test-Retest Characterization of PET with [(18)F]FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes.Vesicular monoamine transporter, type 2 (VMAT2) expression as it compares to insulin and pancreatic polypeptide in the head, body and tail of the human pancreas.In vivo beta-cell imaging with VMAT 2 ligands--current state-of-the-art and future perspective.Life and death of β cells in Type 1 diabetes: A comprehensive review.Molecular imaging of the pancreas in small animal modelsLocalization and expression of VMAT2 aross mammalian species: a translational guide for its visualization and targeting in health and disease.Species-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models.Molecular imaging: a promising tool to monitor islet transplantation.The role of pancreatic imaging in monogenic diabetes mellitus.Biomarkers in type 1 diabetes: application to the clinical trial setting.Pancreas-Specific Delivery of β-Cell Proliferating Small Molecules.Failed PET Application Attempts in the Past, Can We Avoid Them in the Future?Aptamers: novel diagnostic and therapeutic tools for diabetes mellitus and metabolic diseases.Inside the pancreas: progress and challenges of human beta cell mass quantification.Islet grafting and imaging in a bioengineered intramuscular space.Non-invasive quantification of the beta cell mass by SPECT with ¹¹¹In-labelled exendin.Translational Molecular Imaging of Diabetes
P2860
Q36395175-43A2E79D-3A80-43DA-9F27-9D4B5209B7A3Q36665699-EC63490E-6F39-4D8D-9637-6CF693C44735Q36707357-65125EE9-6A96-4AA8-9C47-3928F22BB250Q36773604-226EB98E-5A6A-4501-96A4-2AC7B0DF053BQ36995568-392CD0F7-E3E8-4A28-81EA-010A8C2DC4EAQ37086754-15D53C34-FA51-4B1C-8B03-A0662E4D60A7Q37591449-31637846-CB0D-4340-AFEB-0B13D684BBABQ37640085-F3350D06-5BE2-43C7-A50D-FC3A5EEF00DFQ37947597-1A372205-90B7-4BBA-BB62-A8DA487DE9CDQ37962349-EF2BD844-7708-475E-BD8D-A3879847702FQ38220863-8A76E773-6C3C-48D3-8C79-37A929ABBB67Q38776961-A537C591-F02B-4A04-BCE8-3EC5CBF9E47CQ38800009-5F2283E9-501F-4454-912E-ECECD05AE0D0Q39009713-36265999-654B-49CB-AB4E-140A8E84179BQ39238015-E40E08F1-0130-4910-8F1E-C091D4E26986Q42716769-DF7872EF-4168-4F77-A94F-B7CA87C52636Q53080980-E8C6F119-61C8-47D9-B536-D0BC674D0115Q58630430-9AA8F0BE-20CF-4860-A8CD-FD5B495C59F9
P2860
VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.
@ast
VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.
@en
VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.
@nl
type
label
VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.
@ast
VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.
@en
VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.
@nl
prefLabel
VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.
@ast
VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.
@en
VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.
@nl
P2093
P1476
VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease
@en
P2093
P2860
P304
P356
10.1111/J.1463-1326.2008.00943.X
P478
10 Suppl 4
P577
2008-11-01T00:00:00Z